Details for New Drug Application (NDA): 019545
✉ Email this page to a colleague
The generic ingredient in DIDRONEL is etidronate disodium. There are four drug master file entries for this compound. Additional details are available on the etidronate disodium profile page.
Summary for 019545
Tradename: | DIDRONEL |
Applicant: | Mgi Pharma Inc |
Ingredient: | etidronate disodium |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 50MG/ML | ||||
Approval Date: | Apr 20, 1987 | TE: | RLD: | No |
Expired US Patents for NDA 019545
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Mgi Pharma Inc | DIDRONEL | etidronate disodium | INJECTABLE;INJECTION | 019545-001 | Apr 20, 1987 | ⤷ Sign Up | ⤷ Sign Up |
Mgi Pharma Inc | DIDRONEL | etidronate disodium | INJECTABLE;INJECTION | 019545-001 | Apr 20, 1987 | ⤷ Sign Up | ⤷ Sign Up |
Mgi Pharma Inc | DIDRONEL | etidronate disodium | INJECTABLE;INJECTION | 019545-001 | Apr 20, 1987 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription